The Inclusion of Timolol and Lisinopril in Calcium Phosphate Particles Covered by Chitosan: Application in Ophthalmology


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Chitosan-covered calcium phosphate nanoparticles with the mean dynamic radii of 30 to 130 nm and ζ-potential of +22 ± 4 mV containing timolol and lisinopril are prepared and characterized. These particles are formed by the amorphous phase represented by amorphous calcium phosphate Cax(PO4)y · zH2O and the crystalline phase represented by hydrated calcium hydrophoshate (brushite) CaHPO4 · 2H2O. The experiments in vivo demonstrated that the inclusion of timolol into calcium phosphate particles covered with chitosan substantially prolonged its effect on the intraocular pressure.

About the authors

I. I. Nikolskaya

Department of Chemistry

Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 119991

O. V. Beznos

Helmholtz Moscow Research Institute of Eye Diseases

Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 105062

A. I. Eltsov

Department of Chemistry

Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 119991

I. V. Gachok

Department of Chemistry

Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 119991

N. B. Chesnokova

Helmholtz Moscow Research Institute of Eye Diseases

Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 105062

V. P. Varlamov

Federal Research Center “Fundamentals of Biotechnology,”

Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 119071

O. A. Kost

Department of Chemistry

Author for correspondence.
Email: olga.a.kost@gmail.com
Russian Federation, Moscow, 119991

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Allerton Press, Inc.